Antiphospholipid antibodies and renal involvement

American Journal of Nephrology

Volumn 30, Issue 5, 2009, Pages 405-412

  Gigante, Antonietta ^a   Gasperini, Maria Ludovica ^a   Cianci, Rosario ^a   Barbano, Biagio ^a   Giannakakis, Konstantinos ^a   Di Donato, Domenico ^a   Fuiano, Giorgio ^b   Amoroso, Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Antiphospholipid syndrome nephropathy; Systemic lupus erythematosus nephritis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; RITUXIMAB; WARFARIN;

ABDOMINAL DISEASE; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; ARTERY THROMBOSIS; BRAIN ATROPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FETUS WASTAGE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; NEUROLOGIC DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THROMBOSIS PREVENTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; KIDNEY; KIDNEY DISEASES; RISK FACTORS;

EID: 69149103389     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235941     Document Type: Review

References (40)

1. Hughes GRV: Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ 1983 ; 287: 1088-1089.
2. Cervera R: Lessons from the 'Euro-Phospholipid' project. Autoimmun Rev 2008; 7: 174-178.
3. Atanassova PA: Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: An overview. Yonsei Med J 2007; 48: 901-926.
4. Carreras LO, Forastiero RR, Martinuzzo ME: Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000 ; 15: 163-172.
5. 2- glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004 ; 121: 142-149.
6. Rand JH: Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002; 90: 29-37.
7. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA: Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007; 109: 422-430.
8. Sherer Y, Berkun Y, Blank M, Shoenfeld Y: Pathogenesis of the antiphospholipid syndrome. Pediatr Rheumatol Online J 2004; 2: 492-496.
9. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL: Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006; 65: 2-6.
10. Asherson RA, Cervera R, Piette JC, Shoenfeld Y: The antiphospholipid syndrome: History, classification, and differential diagnosis; in Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds): The Antiphospholipid Syndrome. Boca Raton, CRC Press, 1996, pp 3 -12.
11. Bucciarelli S, Espinosa G, Cervera R, et al: European Forum on Antiphospholipid Antibodies - mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006; 54: 2568-2576.
12. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
13. Edwards CJ, Hughes GR: Hughes syndrome (the antiphospholipid syndrome): 25 years old. Mod Rheumatol 2008; 18: 119-124.
14. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
15. Uthman I, Khamashta M: Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum 2006; 35: 360-367.
16. D'Cruz DP: Renal manifestations of the antiphospholipid syndrome. Lupus 2005; 14: 45-48.
17. Hughes GR: The Prosser-White oration 1983 : Connective tissue disease and the skin. Clin Exp Dermatol 1984; 9: 535-544.
18. Nochy D, Daugas E, Droz D, Beaufils H, Grunfeld JP, Piette JC, et al: The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999 ; 10: 507-518.
19. Kleinknecht D, Bobrie G, Meyer O, Noel LH, Callard P, Ramdane M: Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 1989; 4: 854-858.
20. Dayal NA, Isenberg DA: End stage renal failure in primary antiphospholipid syndrome - case report and review of literature. Rheumatology (Oxford) 2003; 42: 1128-1129.
21. Sangle SR, D'Cruz DP: Renal artery stenosis: A new facet of the antiphospholipid (Hughes) syndrome. Lupus 2003; 12: 803-804.
22. Sangle SR, D'Cruz DP, Jan W, Karim MY, Khamashta MA, Abbs IC, Hughes GRV: Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 2003; 62: 999-1002.
23. Rysava R, Zabka J, Peregrin JH, Tesar V, Merta M, Rychlik I: Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant 1998; 13: 2645-2647.
24. Morgan RJ, Feneley RC: Renal vein thrombosis caused by primary antiphospholipid syndrome. Br J Urol 1994; 74: 807-808.
25. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo- Repo M, Aho KND, Palosuo T: Crossreaction between antibodies to oxidized lowdensity lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341 : 923-925.
26. 22-glycoprotein I and anticardiolipin antibodies in oxidatively modified low density lipoprotein uptake by macrophages. Clin Exp Immunol 1997 ; 107: 569-574.
27. Atsumi T, Khamashta MA, Haworth RS, Brooks G, Amengual O, Ichikawa K, et al: Arterial disease and thrombosis in the antiphospholipid syndrome, a pathogenic role for endothelin 1. Arthritis Rheum 1998; 41: 800-807.
28. Sangle SR, D'Cruz DP, Abbs IC, Khamashta MA, Hughes GR: Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) 2005; 44 : 372-377.
29. Fakhouri F, Noël LH, Zuber J, Beaufils H, Martinez F, Lebon P, Papo T, Chauveau D, Bletry O, Grünfeld JP, Piette JC, Lesavre P: The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 2003; 41: 1205-1211.
30. Daugas E, Nochy D, Huong DLT, Duhaut P, Beaufils HLN, Caudwell V, Bariety J, Piette JC, Hill G: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002; 13: 42-52.
31. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM: Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and longterm outcome. Arthritis Rheum 2004; 50: 2569-2579.
32. Moss KE, Isenberg DA: Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 2001; 40: 863-867.
33. Bhandari S, Harnden P, Brownjohn AM, Turney JH: Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. Q J Med 1998; 91: 401-409.
34. Coggins HC, McCluskey RT: Case records of the Massachusetts General Hospital - weekly clinicopathological exercises. Case 11- 2001 : Rapidly progressive renal failure in a 35 -year-old woman with systemic lupus erythematosus. N Engl J Med 2001; 344: 1152-1158.
35. Gronhagen-Riska C, Teppo AM, Helantera A, Honkanen E, Julkunen H: Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. BMJ 1990; 300: 1696-1697.
36. Haviv YS: Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: Cause or effect? Nephron 2000 ; 86: 447-454.
37. Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J: Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 1992; 7: 1194-1198.
38. Wagenknecht DR, Fastenau DR, Torry RJ, Becker DG, LeFor WM, Carter CB, et al: Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transplant Int 2000; 13:S78-S81.
39. Lim W, Crowther MA, Eikelboom JW: Management of antiphospholipid antibody syndrome: A systematic review. JAMA 2006; 295: 1050-1057.
40. Erre GL, Pardini S, Faedda R, Passiu G: Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: A case report and a review of literature. Lupus 2008 ; 17: 50-55.